Status:
UNKNOWN
Continuation of Anti-osteoporotic Treatment 1 Year After Initial Administration
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Osteoporosis Fracture
Eligibility:
All Genders
75+ years
Brief Summary
The aim of this observational study is to assess the obstacles and levers to the continuation of anti-osteoporotic treatment, and to identify those where action could be taken to improve the quality o...
Detailed Description
Selection of patients hospitalized at the Rocheplane Medical Center between June 2021 and May 2022, following a severe osteoporotic fracture and having received a first dose of antiosteoporotic treatm...
Eligibility Criteria
Inclusion
- Hospitalization in CMR's Geriatric Rehabilitation Department between 01/06/2021 and 31/05/2022
- Age: 75 and over
- Admitted with severe post-fracture osteoporosis
- Having received a first dose of antiosteoporotic treatment between the day the fracture occurred and discharge from CMR (either in an inpatient unit prior to CMR, or at CMR)
Exclusion
- Having objected to the use of his/her data for research purposes
- Subject under guardianship or deprived of liberty.
- Pathological fracture
- Anti-osteoporotic treatment prior to fracture
- 1-year follow-up made impossible by lack of contact with patient, family or attending physician.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06024148
Start Date
September 1 2023
End Date
September 1 2024
Last Update
September 6 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.